DICE Therapeutics, Inc. Free Cash Flow 2021-2023 | DICE
DICE Therapeutics, Inc. free cash flow from 2021 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| DICE Therapeutics, Inc. Annual Free Cash Flow |
| 2022 |
-66.56 |
| 2021 |
-40.01 |
| 2020 |
-20.83 |
| DICE Therapeutics, Inc. Quarterly Free Cash Flow |
| 2023-06-30 |
-53.04 |
| 2023-03-31 |
-22.64 |
| 2022-12-31 |
-66.56 |
| 2022-09-30 |
-48.23 |
| 2022-06-30 |
-32.38 |
| 2022-03-31 |
-14.55 |
| 2021-12-31 |
-40.01 |
| 2021-09-30 |
-25.40 |
| 2021-06-30 |
-16.36 |
| 2021-03-31 |
-8.36 |
| 2020-09-30 |
-15.23 |
